Reporting Segment Product Linearrow_drop_up Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Ophthalmic Pharma
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
14.23M 30.93%
Ophthalmic Pharma
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
0.99M 2.15%
Ophthalmic Pharma
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
30.8M 66.92%
keyboard_arrow_right keyboard_arrow_down
Ophthalmic Pharma
Branded Pharmaceuticals (outsourced)
14.23M 30.93%
keyboard_arrow_right
These companies research, develop, and outsource the manufacturing of patented drugs.
keyboard_arrow_right keyboard_arrow_down
Ophthalmic Pharma
Pharmaceutical Patent Licensing
0.99M 2.15%
keyboard_arrow_right
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
keyboard_arrow_right keyboard_arrow_down
Ophthalmic Pharma
Pre-Revenue Pharmaceuticals
30.8M 66.92%
keyboard_arrow_right
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.